Evidence map›Paper›PMID 27098966›Full record

ArticleJournal of the American Heart Association2016

Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic-Banded Mini-Swine.

Jessica A Hiemstra, Dong I Lee, Khalid Chakir, Manuel Gutiérrez-Aguilar, Kurt D Marshall, Pamela J Zgoda, Noelany Cruz Rivera, Daniel G Dozier, Brian S Ferguson, Denise M Heublein and 9 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Chronic interval exercise training prevents BKJournal of applied physiology (Bethesda, Md. : 1985) · 2018
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Jessica A HiemstraDepartment of Biomedical Science, University of Missouri-Columbia, Columbia, MO.
Dong I LeeDivision of Cardiology, Johns Hopkins Medical Institutions, Baltimore, MD.
Khalid ChakirDivision of Cardiology, Johns Hopkins Medical Institutions, Baltimore, MD.
Manuel Gutiérrez-AguilarDepartment of Biomedical Science, University of Missouri-Columbia, Columbia, MO Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO.
Kurt D MarshallDepartment of Biomedical Science, University of Missouri-Columbia, Columbia, MO Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO.
Pamela J ZgodaDepartment of Biomedical Science, University of Missouri-Columbia, Columbia, MO.
Noelany Cruz RiveraDepartment of Biomedical Science, University of Missouri-Columbia, Columbia, MO.
Daniel G DozierDepartment of Biomedical Science, University of Missouri-Columbia, Columbia, MO.
Brian S FergusonDepartment of Biomedical Science, University of Missouri-Columbia, Columbia, MO.
Denise M HeubleinMayo Clinic, Rochester, MN.
John C BurnettMayo Clinic, Rochester, MN.
Carolin ScherfDepartment of Veterinary Pathobiology, University of Missouri-Columbia, Columbia, MO.
Jan R IveyDepartment of Biomedical Science, University of Missouri-Columbia, Columbia, MO.
Gianmaria MinerviniAstraZeneca, Fort Washington, PA.
Kerry S McDonaldDepartment of Medical Pharmacology and Physiology, University of Missouri-Columbia, Columbia, MO.
Christopher P BainesDepartment of Biomedical Science, University of Missouri-Columbia, Columbia, MO Department of Medical Pharmacology and Physiology, University of Missouri-Columbia, Columbia, MO Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO.
Maike KrenzDepartment of Medical Pharmacology and Physiology, University of Missouri-Columbia, Columbia, MO Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO.
Timothy L DomeierDepartment of Medical Pharmacology and Physiology, University of Missouri-Columbia, Columbia, MO.
Craig A EmterDepartment of Biomedical Science, University of Missouri-Columbia, Columbia, MO emterc@missouri.edu.
University of Missouri · USJohns Hopkins University · USMayo Clinic in Arizona · USAstraZeneca (United States) · US

Funding

Molecular Identity of the Cardiac Mitochondrial PoreR01HL094404 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI BAINES, CHRISTOPHER P · 2009 to 2018
$3.6M
SHP2 controls cardiac stress adaptationR01HL116525 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI KRENZ, MAIKE · 2013 to 2016
$1.4M
Cardiomyocyte stretch and intracellular calcium release with advancing ageK01AG041208 · NIA · UNIVERSITY OF MISSOURI-COLUMBIA · PI DOMEIER, TIMOTHY LEE · 2012 to 2016
$545k
NHLBI NIH HHS R01 HL094404NHLBI NIH HHS R01 HL116525NIA NIH HHS K01 AG041208
6 · The paper itself

Abstract

backgroundCyclic guanosine monophosphate-protein kinase G-phosphodiesterase 5 signaling may be disturbed in heart failure (HF) with preserved ejection fraction, contributing to cardiac remodeling and dysfunction. The purpose of this study was to manipulate cyclic guanosine monophosphate signaling using the dipeptidyl-peptidase 4 inhibitor saxagliptin and phosphodiesterase 5 inhibitor tadalafil. We hypothesized that preservation of cyclic guanosine monophosphate cGMP signaling would attenuate pathological cardiac remodeling and improve left ventricular (LV) function. METHODS AND

resultsWe assessed LV hypertrophy and function at the organ and cellular level in aortic-banded pigs. Concentric hypertrophy was equal in all groups, but LV collagen deposition was increased in only HF animals. Prevention of fibrotic remodeling by saxagliptin and tadalafil was correlated with neuropeptide Y plasma levels. Saxagliptin better preserved integrated LV systolic and diastolic function by maintaining normal LV chamber volumes and contractility (end-systolic pressure-volume relationship, preload recruitable SW) while preventing changes to early/late diastolic longitudinal strain rate. Function was similar to the HF group in tadalafil-treated animals including increased LV contractility, reduced chamber volume, and decreased longitudinal, circumferential, and radial mechanics. Saxagliptin and tadalafil prevented a negative cardiomyocyte shortening-frequency relationship observed in HF animals. Saxagliptin increased phosphodiesterase 5 activity while tadalafil increased cyclic guanosine monophosphate levels; however, neither drug increased downstream PKG activity. Early mitochondrial dysfunction, evident as decreased calcium-retention capacity and Complex II-dependent respiratory control, was present in both HF and tadalafil-treated animals.

conclusionsBoth saxagliptin and tadalafil prevented increased LV collagen deposition in a manner related to the attenuation of increased plasma neuropeptide Y levels. Saxagliptin appears superior for treating heart failure with preserved ejection fraction, considering its comprehensive effects on integrated LV systolic and diastolic function.

Indexed as

AdamantaneAnimalsAtrial Natriuretic FactorCyclic GMPDipeptidesDipeptidyl-Peptidase IV InhibitorsDisease Models, AnimalEchocardiographyHypertrophy, Left VentricularMaleNatriuretic Peptide, BrainNeuropeptide YPhosphodiesterase 5 InhibitorsSignal TransductionSwineSwine, MiniatureAdamantaneAtrial Natriuretic FactorCyclic GMPDipeptidesDipeptidyl-Peptidase IV InhibitorsNatriuretic Peptide, BrainNeuropeptide YPhosphodiesterase 5 InhibitorssaxagliptinTadalafilcGMP‐PKG‐PDE5heart failure with preserved ejection fractionpressure‐overloadsaxagliptintadalafil

Identifiers

PMID27098966
PMCPMC4843537
OpenAlexW2337264695

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.